Abstract:OBJECTIVE:To explore the diagnostic value of plasma fetal DNA level in preeclampsia.METHODS:Thirty cases of pregnant women with preeclampsia (at 33 weeks and 3 days) and 30 cases of normal pregnant women (at 34 weeks and 3 days) were selected. All the pregnant women carried a male fetus by B-ultrasound, and were sampled at gestational 20 weeks, third trimester and at 1 hour, 3 hours, 6 hours after delivery. SRY levels in maternal blood were quantitated by polymerase chain reaction (QF-PCR). The endotheliotoxin (ET) level was measured with RIA.RESULTS:(1) Mean fetal DNA level of patients with preeclampsia at 20 weeks of gestation was (316 +/- 61) copy/ml. They were (266 +/- 79) copy/ml, (396 +/- 91) copy/ml, (165 +/- 43) copy/ml for light and severe preeclampsia women and normal pregnant women, respectively. Maternal blood fetal DNA levels in pregnant women with preeclampsia at 20-weeks of gestation were significantly higher than those normal pregnant women (P < 0.01). (2) Mean fetal DNA level of patients with preeclampsia in third trimester was (970 +/- 413) copy/ml. They were (758 +/- 357) copy/ml, (1285 +/- 573) copy/ml, (319 +/- 99) copy/ml for light and severe preeclampsia and normal pregnant women, respectively. Maternal blood fetal DNA levels in pregnant women with preeclampsia in third trimester were significantly higher than those normal pregnant women (P < 0.01). (3) Maternal blood mean fetal DNA level of patients with preeclampsia were (139 +/- 45) copy/ml, (76 +/- 31) copy/ml, (44 +/- 13) copy/ml at 1 hour, 3 hours, and 6 hours after delivery, respectively. Mean fetal DNA level was (102 +/- 42) copy/ml, (57 +/- 25) copy/ml, (36 +/- 12) copy/ml for patients with light preeclampsia, (209 +/- 51) copy/ml, (97 +/- 40) copy/ml, (52 +/- 17) copy/ml for patients with severe preeclampsia, and (33 +/- 13) copy/ml, (9 +/- 5) copy/ml, 0 copy/ml for normal pregnant women. Significant difference was found between preeclampsia and control groups (P < 0.01). (4) The mean endotheliotoxin level for preeclampsia women was (80 +/- 18) ng/L. For light preeclampsia, severe preeclampsia and normal pregnant women ET levels were (74 +/- 14) ng/L, (89 +/- 32) ng/L, (50 +/- 11) ng/L, respectively. ET levels in pregnant women with preeclampsia were significantly higher than those normal pregnant women (P < 0.01). (5) A positive correlation was found between fetal DNA levels and ET levels in preeclampsia group (r = 0.748, P < 0.01).CONCLUSION:The fetal DNA determination may help diagnose preeclampsia.

Analysis of differential protein mass spectrogram in the amniotic fluid of pre-eclampsia and normal pregnancy

Mass Spectrometry-Based Proteomics for Pre-Eclampsia and Preterm Birth

Proteomics Analysis of Differential Protein Expression in Serum of Pregnant Women with Preeclampsia and Acute Phase Protein

Study on Correlation between Changes in Coagulation and Fibrinolysis Related Factors and Incidence of Severe Pre-eclampsia

Proteomic analysis of human serum for Finding pathogenic factors and potential biomarkers in preeclampsia

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Study on the Level Changes of N-terminal Pro-B-type Natriuretic Peptide in the Serum of Patients with Pre-eclampsia and Its Clinical Significance

Placental Proteome Alterations in Women with Intrahepatic Cholestasis of Pregnancy.

Characterization of discriminatory urinary proteomic biomarkers for severe preeclampsia using SELDI-TOF mass spectrometry

Use of data-independent acquisition mass spectrometry for comparative proteomics analyses of sera from pregnant women with intrahepatic cholestasis of pregnancy

Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia.

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Analysis of Expression and Comparative Profile of Normal Placental Tissue Proteins and Those in Preeclampsia Patients Using Proteomic Approaches

Study on the Relation Between Concentration of Circulating Non-Host Fetal DNA in Pregnant Women and Pre-Eclampsia

Proteomic Analysis Reveals Differential Protein Expression in Placental Tissues of Early-Onset Preeclampsia Patients

Proteomic Analysis of Proteins Differentially Expressed in Preeclamptic Trophoblasts

Proteomic Analysis in Placental Trophoblasts of Pre-Eclampia Patients

Comparative Proteomic Profile of the Human Umbilical Cord Blood Exosomes between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry.

Serum markers of pre-eclampsia identified on proteomics.

Isobaric tag for relative and absolute quantitation based quantitative proteomics reveals unique urinary protein profiles in patients with preeclampsia

Comparative Proteomic Analysis of Human Placenta Derived from Assisted Reproductive Technology